testsuites / tst_treatment_blood_dialysateflow_rate

test.py

Clone Tools

Stats

Commits this week: 1
Total Committers: 8
Last Commit: 16 Dec
Commits this week: 1

Lines of code count not available

Commit Activity

Commits By Day In Week
52 week commits volume
Commits By Day In Week
Commits by day
Commits By Day In Week
Commits by hour
Commits By Hour In Day
Commit calendar
 

Most active committers (90 days)

loading
loading
  • last updated a few minutes ago
All Commits Reviews
Constraints
Constraints: committers
 
Constraints: files
Constraints: dates
Sunday 20 Mar 2022
4:09 am

Papiya Mandal <papiya.mandal@ltts.com>

changes as per new src code

Options
    • -1
    • +1
    ./test.py
  2. … 1 more file in changeset.
Thursday 17 Mar 2022
5:37 am

Papiya Mandal <papiya.mandal@ltts.com>

Pushing changes

Options
    • -8
    • +8
    ./test.py
3:14 am

Papiya Mandal <papiya.mandal@ltts.com>

changes as per new src code

Options
    • -1
    • +1
    ./test.py
Wednesday 02 Mar 2022
10:32 am

joseph_varghese <joseph.varghese@ltts.com>

Modified [main treatment flows] based on general comment

Options
    • -1
    • +1
    ./test.py
  2. … 1 more file in changeset.
Friday 25 Feb 2022
8:32 am

joseph_varghese <joseph.varghese@ltts.com>

Merging blood dialysate flow rate testcase after modification

Options
    • -4
    • +9
    ./test.py
7:29 am

joseph_varghese <joseph.varghese@ltts.com>

Modified tst_main treatment blood dialysateflow based on review comments

Options
    • -102
    • +112
    ./test.py
  2. … 3 more files in changeset.
Sunday 20 Feb 2022
6:59 pm

joseph_varghese <joseph.varghese@ltts.com>

Modified tst_main treatment flows

Options
    • -4
    • +3
    ./test.py
10:08 am

joseph_varghese <joseph.varghese@ltts.com>

Merged main treatment flows

Options
    • -73
    • +77
    ./test.py
  2. … 2 more files in changeset.
Friday 18 Feb 2022
1:50 am

joseph_varghese <joseph.varghese@ltts.com>

merged blood_dialysate testcase

Options
    • -0
    • +181
    ./test.py
  2. … 3 more files in changeset.